In a first set of experiments, primary human lung fibroblasts isolated from 8 IPF patients were cultured and treated with GSK621 (a selective activator of AMPK signaling pathway) for 72 h (Fig. 5a). The gene discussed is PRKAA1; the disease is idiopathic pulmonary fibrosis.